FTI Consulting names new managing director.
M2 PHARMA-April 9, 2018-FTI Consulting names new managing director
(C)2018 M2 COMMUNICATIONS
FTI Consulting, a life science and healthcare communications practice, has named Andrew Ward as its new managing director, it was reported on Friday.
Ward joins the group from the Financial Times, where he was the pharmaceuticals correspondent for almost three years, covering the business, finance, science and regulation of the global pharmaceuticals and medical equipment industries. In the new role, Ward will be expected to broaden and deepen FTI Consulting's client base globally.
Ben Atwell, senior managing director and global head of life sciences and healthcare at FTI Consulting, said: "Andrew was one of the sector's most respected reporters during his time covering healthcare, and brings invaluable global perspective to our prestigious client base. We look forward to benefiting from his deep media experience and welcoming him to our global team of over 50 healthcare experts."
((Comments on this story may be sent to email@example.com))
|Printer friendly Cite/link Email Feedback|
|Date:||Apr 9, 2018|
|Previous Article:||Cardiome Pharma signs first amending agreement to amended and restated term loan agreement with CRG Servicing.|
|Next Article:||Tetra Discovery Partners Receives FDA Orphan Drug Designation for BPN14770 for Treatment of Fragile X Syndrome.|